Description: Learn about key actuarial and analytic tools and methodologies used by commercial health insurance to identify and quantify drivers of healthcare cost and utilization (including wasteful and low-value ones) and risks. Use case scenarios in which these tools and methodologies apply, such as underwriting, reinsurance, medical management for population health and chronic diseases, managed care contracting, insurance market reform, provider payment reform, etc., will also be covered. Experience from the U.S., China and other parts of the world will be shared.

Description: From the Valuation Actuary Symposium Proceedings January 1986 Discussion of the development of the valuation actuary concept, various aspects of current regulation, and major features of the valuation actuary concept. Also discussion of the nature of professional liability and the specific legal liability of the valuation actuary. Finally an overview of some methods of limiting that liability.

Description: This session from the 1995 SOA Boston Meeting focuses on the professional issues facing the actuary working in the international environment. Topics to be discussed include licensing, education, code of conduct, and cultural differences. From the Record of the Society of Actuaries, Vol. 21, No. 4a.

Description: With the rapid development of the Insurance market, insurance technology—including online insurance--continues to mature. Zhongan Online invests heavily in fintechand Zhongan Answer, an insurance robo-advisor, launched in 2018, could improve transaction efficiency by using artificial intelligence to communicate in a timely manner and solve the pain point of the perplexed insurance clause. Under a different consumption scenario, Zhongan Answer could reply to users in a timely manner, while also implementing private customized products and services by providing users with personal risk management and insurance assessment solutions so that users could easily and conveniently select the most suitable insurance plan. The intelligent shopping guide system of Zhongan Answer could improve transaction efficiency by analyzing the personal insurance intention and providing the humanized interpretation of insurance clause. Zhongan Answer has served millions of users and supported more than 100,000 insurance-related knowledge points with an accuracy rate over 90%. Zhongan Answer has provided more than four million Q&A services, and its intelligent shopping guide system covers more than 90% of insurance products.

Description: This Open Forum took place as Session 7B at the 1987 Valuation Actuary Symposium. The panelists discuss the conflicting demands between the actuarial profession and company management which face the Valuation Actuary in Canada. Topics of discussion include demands on the actuary from the profession, those in place and those being proposed, and demands from management being placed on the actuary, and how the profession and Canadian Institute of Actuaries may be of assistance.

Description: This is a transcript of a 1982 meeting of the Health Section. Includes presentation and discussion of three papers: a. Cumulative Anti-selection Theory by William F. Bluhm b. Regulatory Monitoring of Individual Health Insurance Policy Experience by John B. Cummings c. Medical Care and Services in Canada by Frank G. Reynolds From Record Vol. 8, No. 4

Description: This session from the 1995 SOA Boston Meeting presents a discussion of actuarial qualification standards, standards of practice SOP, the Code of Professional Conduct and the Actuarial Board for Counseling and Discipline - ABCD. From the Record of the Society of Actuaries, Vol. 21. No. 4b.

Description: Andy Rallis delivers his speech at the presidential luncheon of the SOA 2019 SOA Annual Meeting & Exhibit in Toronto.

Description: In September 2017, the China Insurance Regulatory Commission (CIRC) issued the “C-ROSS Phase II project construction plan”, planned to be used across three years’ time, by perfecting the regulations, improving the operational mechanism and strengthening the regulatory cooperation.